Invention Grant
- Patent Title: Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17F
-
Application No.: US15482260Application Date: 2017-04-07
-
Publication No.: US10308723B2Publication Date: 2019-06-04
- Inventor: Ralph Adams , Andrew George Popplewell , Stephen Edward Rapecki
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB Biopharma SPRL
- Current Assignee: UCB Biopharma SPRL
- Current Assignee Address: BE Brussels
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/46 ; C07K16/24
Abstract:
The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Public/Granted literature
- US20170306052A1 Antibody Molecules Which Bind IL-17A and IL-17F Public/Granted day:2017-10-26
Information query
